The market of biopharmaceutical medicines: A snapshot of a diverse industrial landscape

Frontiers in Pharmacology

Volumn 8, Issue JUN, 2017, Pages

  Moorkens, Evelien ^a   Meuwissen, Nicolas ^a   Huys, Isabelle ^a   Declerck, Paul ^a   Vulto, Arnold G ^b   Simoens, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Biopharmaceutical market; Biosimilar medicine; Investment and development strategies; Off patent biological medicine; Pharmaceutical industry

Indexed keywords

BIOSIMILAR AGENT; INSULIN; MONOCLONAL ANTIBODY;

ARTICLE; BIOTECHNOLOGY; DEVELOPED COUNTRY; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG MARKETING; INDUSTRIAL MEDICINE; INTERSECTORAL COLLABORATION; INVESTMENT; PRESCRIPTION;

EID: 85020692641     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00314     Document Type: Article

References (17)

1. AbbVie (2017). AbbVie Reports Full-Year and Fourth-Quarter 2016 Financial Results. AbbVie. Available online at: https://news.abbvie.com/news/abbvie-reports-full-year-and-fourth-quarter-2016-financial-results.htm (Accessed February 23, 2017)
2. Amgen (2016). Amgen-Products. Amgen [13/09/2016]. Available online at: http://www.amgen.com/products/
3. Calo-Fernández, B., and Martínez-Hurtado, J. L. (2012). Biosimilars: company strategies to capture value from the biologics market. Pharmaceuticals 5, 1393-1408. doi: 10.3390/ph5121393
4. EMA (2016) Applications for New Human Medicines under Evaluation by the Committee for Medicinal Products for Human Use. Available online at: http://www.ema.europa.eu/docs/en_GB/document_library/Report/2016/12/WC500217738.pdf (Accessed January 11, 2017)
5. Evaluate Pharma (2016). World Preview 2016, Outlook to 2022. EvaluatePharma. Available online at: http://info.evaluategroup.com/rs/607-YGS-364/images/wp16.pdf (Accessed January 16, 2017)
6. F. Hoffmann-La Roche Ltd. (2016). Roche-Biotechnology. F. Hoffmann-La Roche Ltd. Available online: http://www.roche.com/research_and_development/what_we_are_working_on/research_technologies/protein-related_technologies.htm (Accessed January 16, 2017)
7. GaBI Online-Generics and Biosimilars Initiative (2015). Biological Patent Expiries: GaBI Online-Generics and Biosimilars Initiative. Available online at: http://www.gabionline.net/Biosimilars/General/Biologicals-patent-expiries (Accessed January 12, 2017)
8. IMS Health (2016). The Impact of Biosimilar Competition. London: IMS Health
9. IMS Institute for Healthcare Informatics (2016). Delivering on the Potential of Biosimilar Medicines-The Role of Functioning Competitive Markets. Parsippany, NJ: IMS Institute for Healthcare Informatics
10. Long, D. (2015). The Business of Biosimilars. Orlando, FL: HDMA Distribution management conference and expo
11. Meuwissen, N. (2016). Wat Zijn de Verschillende Marktstrategieën Van Originele en Biosimilar Geneesmiddelen eens Het Patent en Exclusiviteit van Het Origineel Verlopen Zijn? Leuven: KU Leuven
12. Nguyen, D. (2012). "Biosimilars: What it Takes and What is Needed," in 10th EGA International Symposium on Biosimilar Medicines. (London)
13. O'Donnell, C., and Roumeliotis, G. (2016). Exclusive-Germany's Merck Explores Sale of Biosimilar Drug Business: Sources. Reuters. Available online: http://uk.reuters.com/article/uk-merck-m-a-exclusive-idUKKCN12S2FE (Accessed December 14, 2016)
14. Pharm Exec (2016). Pharm Exec's Top 50 Companies 2016. Pharm Exec. Available online at: http://www.pharmexec.com/2016-pharm-exec-50 (Accessed January 16, 2017)
15. Roche (2014). Roche Position on Similar Biotherapeutic Products-Biosimilars. Roche. Available online at: http://www.roche.com/roche_position_biosimilars.pdf (Accessed January 16, 2017)
16. Roche (2016). EU Approves Second Indication for Subcutaneous Form of Roche's Rituximab. Available online at: http://www.in-pharmatechnologist.com/Drug-Delivery/EU-approves-indication-for-subcutaneous-form-of-Roche-s-MabThera/?utm_source=newsletter_weekly&utm_medium=email&utm_campaign=From%2027-May-2016%20to%2003-Jun-2016&c=3bdWxioI255HXSfoH9tdSJpU6D0%2F5MwZ&p2 (Accessed September 13, 2016)
17. Troein, P. (2017). Market Development in Europe and Globally-A Perspective on Biologicals and Biosimilars. 15th Biosimilar Medicines Conference (Medicines for Europe). London: QuintilesIMS